Pune: Doctors use new antivirus pills, Molnupiravir, even saving even among covid patients recommended with comorbidity, which is at high risk of severe disease development.
“If the patient has a severe developmental risk, they are given a remedy for three days.
We do not use molnupiravir among covid diabetes patients because drug trials do not show their benefits.
In addition, we also do not use drugs on them with Covid history and patients Previously with a low viral load, “said the infectious disease of the hospital Dr.
Prayag Parikshit.
Molnupiravir trials have shown that it can stop the development of Covid infections.
“But the trial included only patients who were not vaccinated.
The trial did not show the benefits of Covid patients suffering from diabetes.
In addition, trials also found that the drug did not help them with a low viral load at the beginning.
It also does not help patients with reinfection, “Dr.
Prayag said.
This drug is contraindicated in pregnancy or in couples who try to get pregnant.
“There are concerns about using drugs in patients with kidney function compromised,” said Dr.
Prayag.
Doctor Aniket Joshi, member of the Association of Indian Doctors, said, “Most patients get better with paracetamol within three days, including those who have comorbidity.
So, the need to use new drugs is not much.
Only people with old age (who have crossed Age of child bearings) with persistent symptoms and moderate diseases especially prescribed drugs.
“Globally, including in India, Molnupiravir is only approved for covid patients with high risk of severe disease development, especially those who have existing conditions (comorbid).